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A series of amino acids conjugated imidazole derivatives were synthesized and characterized by standard spectroscopical techniques. The title compounds 
were evaluated for their in vitro antimicrobial activity against bacteria and fungi by zone of inhibition method. The results showed that this skeletal framework 
exhibited interesting potency as antimicrobial agents. Amongst, compounds 10,11,13,14,16,17 and 18 showed most potent gram negative and gram positive 
antibacterial activity whereas compounds 11,12,14,15,17 and 26 displayed most potent antifungal activity against A. niger and compounds 16,17,18, 21,22 
and 24 exhibited good antifungal activity against F. oxysporum species. On the other hand, conjugates 11,12,13,14,15,16,17 and 18 showed very good 
antioxidant activity compared to commercial standard drugs. The results highlight the amino acids conjugated imidazole derivatives as potential leads for 
designing new future antimicrobial drug candidates possessing good antioxidant properties.
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Introduction 
          Heterocyclic compounds of nitrogen containing five membered 
ring systems have been described for their biological activity against 
various microorganisms [1]. Besides this, the chemistry of imidazoles 
has also been reviewed in literature and a number of derivatives of 
imidazoles serve as valuable therapeutic agents [2]. Considerable 
interest has been created in the chemistry of imidazoles due to their 
versatile therapeutic activities like antibacterial [3,4], antimalarial 
[5], antihypertensive [6], antidepressant [7], antitubecular [8], 
antiviral [9], antiepileptic [10], antirheumatoid arthritis [11], 
anti-inflammatory [12,13], anticancer activities [14,15] etc. The 
emergence of powerful and elegant imidazole has stimulated major 
advances in chemotherapeutic agents of remarkable significance in 
medicine, biology and pharmacy. Besides this, it is also reported that 
imidazole compounds are one of the effective antifungal agents [16]. 
Considering the importance of imidazole, we planned to incorporate 
this crucial moiety in the design of our project.
On the other hand, earlier reports have shown that conjugation of 
different amino acids/ peptides to various biologically active scaffolds 
has fetched remarkable results which are very promising and even 
enthusiastic [17-19]. Further, amino acid/ peptide-based drugs have 
low toxicity, ample bioavailability and permeability, modest potency 
and good metabolic and pharmacokinetic properties [20]. Prompted 
by all these observations and with a further interest to develop 
more biologically active compounds, the present work encompasses 
the synthesis of novel imidazole-based amino acids analogues as 
promising antimicrobial and antioxidant agents.
Material and Methods
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General
Imidazole 1 was gifted from Jubilant Life Sciences Ltd, all other 
chemicals and reagents were obtained from Merck (India) and 
Avra Synthesis (India) which were used directly. Melting point 
was determined on a Superfit melting point apparatus (India) and 
is uncorrected. FT-IR was performed using a Jasco spectrometer 
(Japan) using nujol media. 1H NMR (400 MHz) and 13C NMR 
(100 MHz) spectra were recorded on a Agilent Technologies 
spectrometer (USA) using DMSO (d6) as solvent. High resolution 
mass spectroscopic analysis was performed on a Bruker MicroTOF 
QII mass spectrometer in positive mode. Progress of the reaction 
was monitored by TLC using silica gel coated on glass plates with the 
solvent system comprising chloroform/ methanol/ acetic acid in the 
ratio 98:02:03 (Rfa) and 95:05:03 (Rfb) and the compounds on TLC 
plates were detected by iodine vapors. Chemicals and reagents used 
for antimicrobial studies were of bacteriological grade.
General procedure for N-alkylation
Compound 1 (2.0 g, 0.008 mol) was dissolved in acetone 
and added base K2CO3 (2.3 g, 2 mol) followed by slow addition of 
4-chlorobenzyl chloride (1.33 g, 0.008 mol). Reaction was maintained 
for 10 h at reflux (monitored by TLC), filtered K2CO3, evaporated 
solvent, cooled and recrystallized N-alkylated product 2 from ethanol. 
General procedure for hydrolysis
Compound 2 (2.0 g, 0.0054 mol) was dissolved in methanol, 
added 0.1 N NaOH solution (0.43 g, 0.011 mol) and the reaction was 
maintained for 5 h at 50 °C. Completion of reaction was monitored 
by TLC, cooled and pH was adjusted to 1-2 using dil. HCl solution. 
Compound was extracted into DCM, washed with water, evaporated 
solvent to obtain compound 3.
General procedure for conjugation of 3 with different 
amino acids (HCl.NH2-Xaa-COOMe) where Xaa = Phe, Tyr, 
Trp, Pro, Met and Lys 
To compound 3 (0.002 mol) and HOBt (0.305 g, 0.002 mol) 
dissolved in DMF (10 mL/g of compound) cooled to 0 °C was added 
NMM (0.55 mL, 0.002 mol). EDCI (0.383 g, 0.005 mol) was added 
under stirring while maintaining the temperature at 0 °C. Reaction 
mixture was stirred for an additional 10 min and a pre-cooled solution 
of HCl.NH2-Xaa-COOMe (0.631 g, 0.002 mol) and NMM (0.25 mL, 
0.002 mol) in DMF (10 mL) was added slowly. After 20 min, pH 
of the solution was adjusted to 8 by the addition of NMM and the 
reaction mixture was stirred over night at room temperature. DMF 
was removed under reduced pressure and the residue was poured 
into about 200 mL of ice-cold 90% saturated KHCO3 solution and 
stirred for 30 min. The precipitated product was taken into CHCl3 
and washed with 5% NaHCO3 solution (2×100 mL), water (1×100 
mL), HCl (2×100 mL) and brine (1×100 mL). The organic layer 
was dried over anhydrous Na2SO4 and solvent was removed under 
reduced pressure. The products so obtained were recrystalized from 
ether/petroleum ether to get conjugates 4 (Phe), 5 (Tyr), 6 (Trp), 7 
(Pro), 8 (Met) and 9 (Lys).
General procedure for the synthesis of hydrazides
 Compound 4, 5, 6, 7, 8 and 9 (0.3mmol) was dissolved 
separately in ethanol (2 mL) and hydrazine hydrate (0.03 mL, 2 mol) 
was added slowly and the reaction was maintained at reflux for 12 
h. Completion of the reaction was monitored by TLC, evaporated 
solvent, cooled and poured into ice cold water. Solid separated was 
filtered and dried to obtain 4a, 5a, 6a, 7a, 8a and 9a respectively.
General procedure for the condensation of aldehydes to 
4a, 5a, 6a, 7a, 8a and 9a
 To compound 4a, 5a, 6a, 7a, 8a and 9a (0.3 mmol) and 
benzladehyde (0.3 mmol) dissolved in ethanol (10 mL/g) was added 
few drops of acetic acid as a catalyst which was maintained at reflux 
for 15 h. Completion of the reaction was monitored by TLC, solvent 
was evaporated, cooled and poured into ice cold water precipitate 
is obtained and then filtered, washed with cold water to obtain 
compound (10-27). 
Antibacterial activity
In vitro antibacterial activity was evaluated against human 
pathogens of both gram positive organisms namely X. oryzae and 
gram negative organisms namely E. coli by agar well diffusion method 
[21].
The microorganisms were inoculated in to the sterilized nutrient 
broth and maintained at 37 °C for 24 h. On the day of testing, bacteria 
were subcultured separately into 25 mL of sterilized nutrient broth. 
Inoculated subcultured broths were kept at room temperature for the 
growth of inoculums. Each test compound (10-27) and standard drug 
of 10 mg was dissolved in 10 mL of DMSO to get a concentration of 
1 μg/mL and further diluted to get a final concentration of 50 μg/mL. 
About 15-20 mL of molten nutrient agar was poured into each of the 
sterile plates. With the help of cork borer of 6mm diameter, the cups 
were punched and scooped out of the set agar and the plates were 
inoculated with the suspension of particular organism by spread plate 
technique. The cups of inoculated plates were then filled with 0.1 mL 
of the test solution, Chloromphenicol solution and DMSO (negative 
control). The plates were allowed to stay for 24 h at 37 °C and zone of 
inhibition (mm) was then measured.
Antifungal activity 
In vitro antifungal activity was evaluated against two fungal 
species namely A.niger, and F. oxysporum by agar well diffusion 
method [22].
The fungal strains were subcultured separately into 25 mL of 
sterilized nutrient broth and compounds and standard drug (bavistin) 
of 10 mg was dissolved in 10 mL of DMSO to get a concentration of 
1 mg/ml and further diluted to get a final concentration of 50 μg/mL. 
Molten media of sabouraud agar of 10-15 mL was poured into the 
petri plates and allowed to solidify. Fungal subculture was inoculated 
on the solidified media. With the help of 6 mm cork borer, the cups 
were punched and scooped out of the set agar. The cups of inoculated 
plates were then filled with 0.1 mL of the test solution, bavistin 
solution and DMSO (negative control). The plates were allowed to 
stay for 3 days at room temperature and zone of inhibition (mm) was 
then measured.
Antioxidant activities
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DPPH (1,1-diphenyl-2-picryl-hydrazyl) assay
The radical scavenging activity of DPPH free radicals by 
synthesized compounds were determined according to the reported 
method [23]. Briefly, 50 µL of test compounds was mixed at different 
concentrations (25, 50, 100, 200 and 300 µg/mL) with 1 mL of 0.1 mM 
DPPH in methanol solution and 450 µL of 50 mM Tris HCl buffer 
(pH 7.4). Methanol (50 µL) only was used as the experimental control. 
After 30 min of incubation at room temperature, reduction in the 
number of DPPH free radicals was measured by reading absorbance 
at 517 nm. BHT (butylatedhydroxytoluene) was used as control 
similar to test concentrations. Percent inhibition was calculated from 
the following equation:
% Inhibition =
Absorbance of control - Absorbance of test sample
Absorbance of control[ ]×100
ABTS (2,2-azinobis-(3-ethylbenzothiazoline-6-sufonic 
acid) assay
The ability of the test sample to scavenge ABTS.+ radical cation 
was determined according to the literature method [24] with slight 
modification. The ABTS.+ radical cation was pregenerated by mixing 
7 mM ABTS.+ stock solution with 2.45 mM potassium persulfate 
(final concentration) and incubating for 12-16 h in dark at room 
temperature until the reaction was complete and absorbance was 
stable. Absorbance of the ABTS.+ solution was equilibrated to 0.70 
(± 0.02) by diluting with distilled water at room temperature, then 
2 mL was mixed with different concentration of the test sample (25, 
50, 100, 200, and 300 µg/mL) and the absorbance was measured at 
734 nm after 6 min. The scavenging capability of ABTS.+ radical was 
calculated  using the following equation:
ABTS.+ scavenging effect (%) = [(Ac-As) /Ac] x 100
Where, Ac is the initial concentration of the ABTS.+ and As is the 
absorbance of the remaining concentration of ABTS.+ in the presence 
of compounds.
DMPD (N, N-dimethyl-p-phenylenediamine) assay
The DMPD radical scavenging ability of synthesized compounds 
was determined by the Fogliano et al., method [25] with slight 
modifications by Gulcin [26]. This assay is based on the capacity of 
the extract to inhibit DMPD.+ cation radical formation. Briefly, 105 
mg of DMPD was dissolved in 5 mL of distilled water. Then, 1 mL of 
this solution was added to 100 mL of 0.1 M acetate buffer (pH 5.3). 
DMPD.+ was produced by adding 0.3 mL ferric chloride (0.05 M) to 
this solution. Different concentrations of standard antioxidants or 
synthesized compounds (25-300 μg/mL) were added, and the total 
volume was adjusted to 1 mL with distilled water. One millilitre of 
the DMPD.+ solution was directly added to the reaction mixture. 
The reaction mixtures were incubated in the dark for 15 min. The 
absorbance was measured at 505 nm and percent inhibition was 
calculated according to the formula:
% Inhibition =
Absorbance of control - Absorbance of test sample
Absorbance of control[ ]×100
Results and Discussion
Chemistry
          Starting material 1 was subjected to N-alkylation using benzyl 
chloride that resulted in 2 which was ascertained by the absence 
of NH proton peak. Product 2 on saponification yielded 3 which 
exhibited carboxylic acid peak in its PMR spectrum. This compound 
was conjugated with different amino acids to obtain 4-9 which did 
not have COOH peak and showed –NH peak at δ ~8.00 (1H, s) in 1H 
NMR spectra. Compounds 4-9 was separately reacted with hydrazine 
hydrate to get 4a-9a which was confirmed by disappearance of –OCH3 
peak. The final imines 10-27 were synthesized by condensation of 4a-
9a with substituted aldehydes (Scheme). Synthesis were confirmed by 
the presence of all requisite peaks and absence of extraneous peaks in 
1H NMR and 13C NMR spectra and also mass values were in accordance 
with the mol. wt. calculated. The analytical and spectroscopic data of 
the synthesized compounds are given in Table 1.
Biological evaluation
Antimicrobial activity
 The Schiff bases of imidazole-amino acid conjugates were 
evaluated for their antibacterial studies against both gram-positive 
and gram-negative bacteria namely X. oryzae and E. coli respectively 
and antifungal studies against A. niger and F. oxysporum. Synthesized 
compounds exhibited a significant broad spectrum inhibitory effect 
against all the tested microorganisms. The result obtained as zone 
of inhibition (mm) is presented in Table 2. The standard drugs 
chloromphenicol and bavistin were used as standards for antibacterial 
and antifungal activities respectively.
Previous reports have shown that there is no significant activity 
with just imidazoles linked amino acids [27,28]. Further, derivatives 
of amino acids-heterocycle conjugates have exhibited promising 
results and in continuation it was decided to introduce different 
aldehydes viz. dihydroxy, trihydroxy and trimethoxy benzaldehyde 
in the present study to obtain imines 10-27. Among the twenty 
naturally occurring amino acids, selective moieties like Phe, Trp 
and Tyr (aromatics); Pro (an imine); Met (thio) and Lys (basic) were 
used in the current investigation. Amongst, compounds 10-18, 21 
and 27 appeared to be more active than the standards which may 
be due to the presence of aromatic side chains in Phe, Trp and Tyr 
and also could be due to more hydrophobicity of these amino acids 
along with the presence of more electron donating groups like OH 
and OCH3 present on the other end of the molecules.  Together these 
parameters would have contributed to the superior activity. And 
also it is observed that compounds with trihydroxy benzaldehyde 
derivatives have shown enhanced activity compared to rest of the 
analogues which imparts that these hydroxyl functions play a key role 
in enhancing the activity. On the other hand, compounds containing 
thio group (22-24) have shown slightly decreased activity than Pro 
(19-21) which are further less active than Lys (25-27) analogues and 
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Mol. Wt. Actual MS IR (ν cm
-1) and NMR (CDCl3, δ ppm) 
10 0.61 89 103-105 617.10 618.3
IR: 3250 (NH), 1690 (CO), 1590 (-HC=N-)
1H NMR: 0.90 (3H,t,-CH3 of propyl), 1.57 (6H,s,-CH3), 1.68 (2H,m,-
CH2 of propyl), 2.45 (2H,t,-CH2 of propyl),  2.92 (2H,t,β–CH2), 4.92 
(1H,t,α-CH), 4.97 (2H,s,-CH2 of benzyl), 5.0 (2H, s,-OH), 6.66-
7.22 (12H,m,Ar-H), 8.1 (1H,s,-HC=N-), 8.8  (2H,d,-NH)
13C NMR:13.6, 24.4, 28.5, 31.1, 37.8, 40.1, 55.2, 69.7, 115.8, 
115.8., 116.2, 117.5, 123.2, 126.4, 128.2, 128.7, 130.9, 131.2, 
133.9, 138.7, 143.1, 147.2, 148.6, 150.1, 155.6, 156.5, 160.6, 
177.2
11 0.59 91 101 633.30 634.5
IR: 3260 (NH), 1695 (CO), 1620 (-HC=N-)
1H NMR: 0.93 (3H,t,-CH3 of propyl), 1.54 (6H,s,-CH3), 1.70 (2H,m,-
CH2 of propyl), 2.48 (2H,t,-CH2 of propyl),  2.89 (2H,t,β–CH2), 4.88 
(1H,t,α-CH), 4.90 (2H,s,-CH2 of benzyl), 5.6 (3H, s,-OH), 6.70-
7.30 (11H,m,Ar-H), 8.1 (1H,s,-HC=N-), 8.6 (2H,d,-NH).
13C NMR:14.2, 26.2, 27.6, 33.1, 38.4, 41.2, 55.8, 66.6, 116.4, 
117.5, 118.8, 119.2, 121.6, 128.6, 128.9, 130.5, 131.4, 131.9, 
133.2, 138.4, 140.9, 146.0, 149.5, 151.4, 154.1, 156.0, 161.4, 
175.8
12 0.62 92 113-114 675.0 676.1
 IR: 3258 (NH), 1680 (CO), 1640 (-HC=N-)
1H NMR: 1.0 (3H,t,-CH3 of propyl), 1.55 (6H, s, -CH3), 1.69 
(2H,m,-CH2 of propyl), 2.31 (2H,t,-CH2), 2.42 (2H,t,-CH2 of 
propyl), 3.09 (1H,m,β-CH2), 3.53 (9H,s,-OMe), 4.95 (1H,α,-
CH), 4.92 (2H,s,-CH2of benzyl),  6.6-7.22 (11H,m,Ar-H), 8.2 
(2H,d,NH), 8.2 (1H,s,-HC=N-)
13C NMR: 14.5, 26.0, 27.9, 30.1, 38.4, 41.2, 53.7, 56.2, 63.6, 
105.1, 114.8, 126.1, 126.6, 129.1, 132.2, 133.8, 134.0, 134.4, 
136.9, 140.2, 143.2, 150.5, 150.8, 151.8, 156.0, 156.4, 176.6
13 0.55 85 120-122 633.5 634.5
IR: 3264 (NH), 1691 (CO), 1640 (-HC=N-)
1H NMR: 0.92 (3H,t,-CH3 of propyl), 1.60 (6H,s,-CH3), 1.64 (2H,m,-
CH2 of propyl), 2.41 (2H,t,-CH2 of propyl), 2.92 (2H,t,β –CH2), 4.92 
(1H,t,α-CH),  4.99 (2H,s,-CH2 of benzyl), 5.2 (3H, s,-OH), 6.66-
7.18 (11H,m,-Ar-H), 8.0 (1H,s,-HC=N-), 8.3 (2H,d,-NH)
13C NMR: 13.7, 24.2, 28.3, 31.0, 37.9, 40.2, 55.3, 69.8, 115.7, 
115.8., 116.4, 117.4, 123.2, 128.8, 129.2, 130.5, 131.3, 132.1, 
134.4, 138.6, 143.0, 147.4, 149.6, 150.7, 155.7, 156.4, 160.8, 
177.0
14 0.58 92 Gum 649.10 650.5
IR: 3245 (NH), 1698 (CO), 1630 (-HC=N-)
1H NMR: 0.93 (3H,t,-CH3 of propyl), 1.54 (6H,s,-CH3), 1.70 
(2H,m,-CH2 of propyl) ,2.48 (2H,t,-CH2 of propyl),  2.89 (2H,t,β 
–CH2), 4.88 (1H,t,α-CH) 4.93 (2H,s,-CH2 of benzyl), 5.6 (4H, s,-
OH), 6.70-7.30 (10H,m,-Ar-H), 8.1 (1H,s,-HC=N-)  8.6 (2H,d,-NH)
13C NMR: 13.9, 24.8, 28.7, 32.0, 37.7, 40.3, 54.9, 69.8, 115.4, 
115.5, 115.9, 117.2, 122.8, 128.6, 129.1, 130.6, 131.4, 131.9, 
134.3, 138.5, 139.9, 147.2, 149.5, 150.6, 155.7, 156.2, 160.6, 
177.2
15 0.70 88 122 691.20 692.2
IR: 3246  (NH), 1686 (CO), 1595 (-HC=N-)
1H NMR: 1.0 (3H,t,-CH3 of propyl), 1.55 (6H, s, -CH3), 1.69 (2H,m,-
CH2 of propyl), 2.31 (2H,t,-CH2), 2.42 (2H,t,-CH2 of propyl), 3.09 
(1H,m, β-CH2), 3.53 (9H,s,-OMe), 4.95 (1H,α,-CH), 4.98 (2H,s,-
CH2 of benzyl), 5.40 (1H,s,-OH), 6.6-7.22 (11H,m,Ar-H), 8.2 
(2H,d,NH), 8.2 (1H,s,-HC=N-)
13C NMR: 13.5, 24.3, 28.5, 31.3, 37.8, 40.1, 55.4, 56.2, 64.8, 
106.5, 115.8, 128.0, 128.6, 129.2, 130.4, 131.5, 132.0, 134.4, 
138.6, 141.5, 143.0, 150.7, 150.9, 150.9, 155.7, 156.4, 177.5
16 0.66 96 Gum 657.14 658.5
IR: 3266(NH),1670 (CO), 1590 (-HC=N-)
1H NMR: 0.82 (3H,t,-CH3 of propyl), 1.37 (6H,s,-CH3),  1.68 
(2H,m,-CH2 of propyl), 2.45 (2H,t,-CH2 of propyl), 3.06 (2H,d,β-
CH2), 4.92 (1H, t,δ -CH), 5.40 (2H,s, -OH), 4.99 (2H,s,- CH2 of 
benzyl), 6.6-7.18 (11H,m,Ar-H), 8.4 (1H,s,-HC=N-), 10.1 (2H,t,-
NH)
13C NMR: 12.9, 22.2, 28.6, 32.0, 31.6, 40.4, 56.4, 69.8, 110.9, 
111.1, 116.4, 116.9, 118.2, 120.6, 121.1, 122.2, 123.1, 127.6, 
127.9, 128.6, 130.4, 131.3, 134.4, 136.4, 138.6, 143.0, 147.3, 
149.6, 150.4, 156.4, 160.4, 178.0
Table 1: Physical and analytical data of the conjugated compounds (10-27)
17 0.57 86 89-90 672.2 673.5
IR: 3261 (NH), 1675 (CO), 1625 (-HC=N-)
1H NMR: 0.88 (3H,t,-CH3 of propyl), 1.34 (6H,s,-CH3), 1.64 (2H,m,-
CH2 of propyl), 2.45 (2H,t,-CH2 of propyl), 3.16 (2H,d,β-CH2), 4.90 
(1H, t,δ -CH), 5.39 (3H,s,-OH), 4.99 (2H,s,-CH2 of benzyl), 6.6-
7.18 (10H,m,Ar-H), 8.1 (1H,s,-HC=N-), 10.1 (2H,t,-NH)
13C NMR: 11.7, 23.1, 27.5, 31.6, 31.9, 40.1, 54.2, 66.5, 109.0, 
116.4, 118.2, 120.6, 121.1, 122.2, 127.6, 127.9, 128.6, 129.2, 
130.4, 131.3, 134.4, 136.4, 143.0, 143.1, 146.7, 148.5, 151.2, 
155.1, 159.0, 176.2
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18 0.60 90 96 714.29 715.4
IR: 3258 (NH),1660 (CO), 1605 (-HC=N-) 
1H NMR: 0.82 (3H,t,-CH3 of propyl), 1.42 (6H,s,-CH3), 1.55 (2H,m,-
CH2 of propyl), 2.51(2H,t,-CH2 of propyl), 3.16 (2H,d,β-CH2), 3.23 
(2H,d,β-CH2), 3.77 (9H,s,-OCH3), 4.88 (1H,t,α-CH), 5.0 (2H,s,- 





19 0.55 92 102 567.10 568.4
IR: 3244 (NH), 1685(CO), 1650 (-HC=N-)
1H NMR: 0.86 (3H,t,-CH3 of propyl), 1.54 (2H,m,β –CH2), 1.65 
(6H,s,-CH3), 1.70 (2H,m,α-CH2), 1.72 (2H,m,-CH2 of propyl), 2.56 
(2H,t,-CH2 of propyl), 3.29 (2H,t,α –CH2), 4.29 (1H,t,δ-CH2), 5.2 ( 
2H,s,- CH2 of benzyl), 5.40 (2H,s, -OH), 6.66-7.18 (7H,m,Ar-H), 
8.1 (1H,s,-HC=N-)  8.6 (1H,d,-NH)
13C NMR: 12.7, 24.1, 26.0, 31.0, 32.1, 37.0, 55.0, 65.4, 108.6, 
110.9, 116.2, 116.8, 119.0, 122.0, 122.3, 122.8, 123.0, 126.5, 
127.0, 128.8, 130.4, 131.0, 133.8, 135.5, 137.5, 142.0, 148.2, 
149.1, 150.7, 160.6, 169.0
20 0.60 90 109-110 583.20 584.5
IR : 3256 (NH),1669 (CO), 1635 (-HC=N-)
1H NMR : 1.02 (3H,t,-CH3 of propyl), 1.52 (2H,m,β-CH2), 1.56 
(6H,s,-CH3), 1.68 (2H,m,-CH2 of propyl), 1.71 (2H,m,γ-CH2), 2.32 
(2H,t,-CH2 of propyl), 3.30 (2H,s,-CH2 of propyl), 4.29 (1H,t,δ-CH), 
5.03 (3H,s,-OH), 6.5-7.15 (6H,s,Ar-H), 8.0 (1H,s,-NH), 8.3 (1H,s,-
HC=N-)
13C NMR: 15.1, 20.4, 24.2, 25.1, 28.3, 39.6, 55.0, 64.1, 106.3, 
110.4, 115.8, 118.5, 121.3, 126.4, 128.3, 129.4, 130.1, 132.1, 
134.1, 138.3, 138.6, 140.4, 148.8, 152.2, 154.3, 164.8, 172.7
21 0.68 93 Gm 625.27 626.2
IR: 3244 (NH),1692 (CO), 1625 (-HC=N-) 
1H NMR: 0.99 (3H,t,-CH3 of propyl), 1.49 (2H,m,β-CH2), 1.57 
(6H,s,-CH3), 1.62 (2H,m,-CH2 of propyl), 1.72 (2H,m,γ-CH2), 2.30 
(2H,t,-CH2 of propyl), 3.30 (2H,s,-CH2 of propyl), 4.31 (1H,t,δ-
CH), 5.13 (9H,s,-OMe), 6.5-7.15 (6H,s,Ar-H), 8.1 (1H,s,-NH), 8.4 
(1H,s,-HC=N-)
13C NMR: 15.0, 20.2, 30.3, 30.6, 31.2, 39.3, 54.2, 55.0, 68.0, 
106.7, 110.8, 113.0, 118.0, 119.1, 122.2, 122.9, 128.8, 128.1, 
131.3, 134.4, 138.4, 141.5, 143.0, 150.9, 150.9, 160.8, 168.0
22 0.55 94 Gum 587.2 588.6
IR: 3267 (NH),1700 (CO), 1610 (-HC=N-) 
1H NMR: 0.99 (3H,t,-CH3 of propyl), 1.39 (6H,s,-CH3), 1.62 (2H,m,-
CH2 of propyl), 2.09 (3H,s,δ-CH3), 2.53 (2H,t,-CH2 of propyl), 
2.92 (2H,d,β-CH2), 4.92 (1H,t,α-CH), 4.99 (2H,s,-CH2 of benzyl)), 
5.13 (2H,s,-OH), 6.6-7.10 (7H,m,Ar-H), 8.15 (1H,s,-HC=N-) 8.21 
(1H,s,-NH)
13C NMR: 14.8, 17.1, 24.7, 27.3, 30.1, 36.5, 40.0, 50.6, 69.8, 
114.4, 115.2, 116.4, 121.1, 123.2, 126.8, 127.8, 128.9, 130.3, 
131.0, 134.4, 138.6, 147.4, 149.6, 150.7, 156.4, 166.9
23 0.56 88 Gum 603.19 604.3
IR : 3270 (NH),1695 (CO), 1595 (-HC=N-)
1H NMR: 1.1 (3H,t,-CH3 of propyl), 1.35 (6H,s,-CH3), 1.58 (2H,m,-
CH2 of propyl), 2.16 (3H,s,δ-CH3), 2.54 (2H,t,-CH2 of propyl), 2.88 
(2H,d,β-CH2), 4.88 (1H,t,α-CH), 4.96 (2H,s,-CH2 of benzyl),5.11 
(3H,s,-OH), 6.6-7.10 (6H,m,Ar-H), 8.15 (1H,s,-HC=N-), 8.20 
(1H,s,-NH)
13C NMR: 14.5, 21.2, 29.3, 32.2, 32.6, 47.9, 51.9, 71.2, 109.0, 
115.2, 118.1, 119.4, 128.8, 130.5, 138.2, 143.0, 147.6, 148.5, 
150.1, 151.2, 154.1, 160.8, 171.6
24 0.60 92 108 645.24 646.3
IR: 3240 (NH),1689 (CO), 1645 (-HC=N-)
1H NMR: 0.90 (3H,t,-CH3 of propyl), 1.35 (6H,s,-CH3), 1.58 (2H,m,-
CH2 of propyl), 2.16 (3H,s,δ-CH3), 2.54 (2H,t,-CH2 of propyl),3.07 
(2H,d,β-CH2), 4.88 (1H,t,α-CH), 4.96 (2H,s,-CH2 of benzyl), 5.20 
(9H,s,-OCH3), 6.6-7.10 (6H,m,Ar-H), 8.0 (1H,s,-HC=N-), 8.10 
(1H,s,-NH)
13C NMR: 11.6, 17.2, 24.2, 26.1, 31.1, 31.4, 52.8, 56.2, 67.2, 
106.7, 114.1, 116.7, 128.1, 131.3, 134.4, 141.0, 144.8, 147.7, 
146.0, 149.6, 150.9, 154.0, 161.5, 169.5
25 0.56 91 118 686.27 687.3
IR: 3243 (NH),1695 (CO), 1630 (-HC=N-)
1H NMR: 0.88 (3H,t,-CH3 of propyl), 1.29 (2H,m,γ-CH2), 1.36 
(6H,s,-CH3), 1.37 (2H,m,-CH2 of propyl), 1.41 (2H,m,δ-CH2), 
1.96 (2H,t,-CH2 of propyl), 2.55 (2H,t,ω-CH2), 2.46 (2H,s,-CH2 of 
benzyl), 3.81 (2H,d,-CH2 of benzyl), 4.51   (1H,t,-CH), 5.12 (2H,s,-
OH), 6.6-7.22 (12H,m,Ar-H), 8.0 (3H,s,-NH), 8.1 (1H,s,-HC=N-)
13C NMR: 13.6, 23.1, 26.3, 32.2, 32.6, 37.0, 51.9, 52.8, 56.2, 69.8, 
116.3, 117.0, 118.4, 126.0, 127.8, 128.7, 134.3, 138.6, 139.5, 
148,7, 149.0, 150.7, 156.4, 162.4, 170.3
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26 0.59 86 Gum 702.32 703.3
IR: 3260 (NH),1698 (CO), 1620 (-HC=N-)
1H NMR: 0.96 (3H,t,-CH3 of propyl), 1.30 (2H,m,γ-CH2), 1.33 
(6H,s,-CH3), 1.27 (2H,m,-CH2 of propyl), 1.42 (2H,m,δ-CH2), 
1.88 (2H,t,-CH2 pf propyl), 2.45 (2H,t,ω,-CH2), 2.54 (2H,s,-CH2 of 
benzyl), 3.80 (2H,d,-CH2 of benzyl), 4.49 (1H,t,-CH), 5.10 (3H,s,-
OH), 6.6-7.22 (12H,m,Ar-H), 8.2 (3H,s,-NH), 8.3 (1H,s,-HC=N-)
13C NMR: 13.7, 22.6, 24.2, 28.3, 28.9, 31.0, 32.6, 45.7, 56.2, 58.7, 
68.5, 69.8, 116.3, 117.3, 118.5, 127.2, 127.7, 129.0, 134.3, 138.6, 
141.2, 148.7, 149.0, 150.7, 156.4, 165.4, 171.6
27 0.60 90 128 744.37 745.5
IR: 3256 (NH),1696 (CO), 1610 (-HC=N-)
1H NMR: 0.90 (3H,t,-CH3 of propyl), 1.33 (2H,m,γ-CH2), 1.35 
(6H,s,-CH3), 1.38 (2H,m,-CH2 of propyl),  1.41 (2H,m,δ-CH2), 
1.96 (2H,t,-CH2 of  propyl), 2.55 (2H,t,ω,-CH2), 2.46 (2H,s,-CH2 of 
benzyl), 3.81 (2H,d,-CH2 of benzyl), 4.51 (1H,t,-CH), 5.05 (9H,s,-
CH3), 6.6-7.22 (12H,m,Ar-H), 8.0 (3H,s,-NH), 8.1 (1H,s,-HC=N-)
13C NMR: 12.5, 24.1, 27.3, 31.8, 33.4, 37.0, 51.9, 52.8, 54.3, 68.6, 
115.8, 116.1, 118.2, 118.5, 129.2, 132.1, 135.3, 138.4, 148.7, 
149.6, 151.6, 155.7, 156.2, 160.8, 171.2
Entry
Antibacterial activity Antifungal activity Antioxidant activity
Zone of inhibition (mm)  ± SD (n=3) IC50 µg/Ml
E. coli X. oryzae A. niger F. oxysporum DPPH ABTS DMPD
1 3±0.12 2±0.63 4±0.42 3±0.40 220±2.01 175±2.15 180±1.45
10 16±0.52 14±0.20 15±0.12 5±0.20 40±0.98 40±0.46 45±0.47
11 18±0.20 12±0.52 18±0.22 7±0.52 25±0.66 35±0.79 35±0.52
12 15±0.50 14±0.35 16±0.52 8±0.2 35±1.02 40±0.64 40±0.95
13 17±0.50 14±0.41 14±0.44 5±0.10 35±0.89 35±0.43 40±0.15
14 20±0.41 16±0.50 20±0.36 6±0.40 20±0.49 30±0.63 30±0.65
15 16±0.46 10±0.15 18±0.10 6±0.25 35±0.65 40±0.14 35±0.24
16 20±0.45 14±0.15 15±0.40 10±0.33 30±0.78 35±0.57 35±0.65
17 22±0.47 16±0.25 16±0.25 12±0.40 20±0.61 25±0.69 20±0.54
18 19±0.41 15±0.26 10±0.33 11±0.25 30±0.43 35±0.52 40±0.26
19 12±0.50 10±0.30 14±0.40 9±0.31 60±0.55 45±0.48 40±0.54
20 14±0.20 14±0.20 16±0.25 9±0.10 55±1.04 35±0.33 35±0.25
21 11±0.40 11±0.10 10±0.33 10±0.40 70±1.22 45±0.49 40±0.45
22 10±0.45 8±0.20 9±0.12 11±0.25 95±1.69 50±0.49 80±0.59
23 10±0.36 7±0.10 12±0.22 10±0.33 75±1.64 45±0.43 65±0.65
24 9±0.30 6±0.20 11±0.30 8±0.40 80±1.69 50±0.58 90±0.45
25 13±0.35 9±0.20 13±0.33 9±0.25 65±0.98 60±0.55 80±0.26
26 14±0.30 12±0.20 15±0.35 7±0.32 60±0.24 75±1.02 85±0.47
27 12±0.35 10±0.26 16±0.44 9±0.21 70±0.66 85±1.54 95±1.23
Chloromphenicol 14±0.65 10±0.24 - - - - -
Bavistin - - 13±0.94 8±0.15 - - -
BHA - - - - 55±0.52 45±0.54 50±0.56
AA - - - - 55±0.69 50±0.66 60±0.42
GA - - - - 60±0.48 50±0.49 55±0.26
Table 2: Antimicrobial and Antioxidant activity of synthesized derivatives
this trend in activity reveals that presence of basic moiety is more 
helpful in obtaining good results. Further these compounds are found 
to be more selective in arresting the growth of A. niger fungus than 
F. oxysporum. 
In vitro antioxidant activities of all the synthesized compounds 
were evaluated by (i) 1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay, 
an convenient technique for screening the antioxidant activities of 
the antioxidants; (ii) 2,2-azinobis-3-ethylbenzothiazoline-6-sufonic 
acid (ABTS) cation radical assay which is a conventional and 
excellent model for assessing the antioxidant activities of hydrogen 
donating and chain breaking antioxidants [29]; and (iii) N,N-
dimethyl-p-phenylenediamine dihydrochloride (DMPD) cation 
radical assay which is similar to the DPPH radical scavenging assay. 
The IC50 values is the effective concentration at which 50% of the 
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radicals were scavenged, were calculated to evaluate the antioxidant 
activities. A lower IC50 value indicate greater antioxidant activity. IC50 
values of lower than 10 mg/mL usually implied effective activities 
in antioxidant properties [30]. The IC50 of butylatedhydroxylanisole 
(BHA), ascorbic acid (AA) and gallic acid (GA) was also determined 
for comparison. The results are presented in Table 2.
Most of the synthesized analogues showed potent antioxidant 
activities especially 11, 12, 13, 14, 15, 16, 17 and 18 showed excellent 
radical scavenging activities with IC50 values 25, 35, 35, 20, 35, 30, 
20 and 30 µg/mL respectively in DPPH assay much better than 
the standard BHA (IC50 = 55 µg/mL). In ABTS+ radical scavenging 
assay, the compounds 11, 12, 13, 14, 15, 16, 17 and 18 showed potent 
antioxidant activity with IC50 values 35, 40, 35, 30, 40, 35, 25 and 
35 µg/mL respectively which is much better than the commercial 
standards AA (IC50= 55 µg/mL). The compounds 11, 12, 13, 14, 15, 
16, 17 and 18 also exhibited striking antioxidant activity with IC50 
values 35, 40, 40, 30, 35, 35, 20 and 40 µg/mL respectively which 
is better than the standards BHA (IC50 = 50 µg/mL), AA (IC50= 60 
µg/mL) and GA (IC50 = 55 µg/mL) in DMPD assay. In all the three 
assays performed, compounds 11, 12, 13, 14, 15, 16, 17 and 18 showed 
excellent antioxidant activities with IC50 values much lower than the 
standards. The IC50 values of these compounds have antioxidant 
activities lower than 10 mg/mL demonstrating greater capacity in all 
the three assays. On the basis of the above observation, compounds 
having –OH (phenolic), –indole and phenyl ring (11, 12, 13, 14, 
15, 16, 17 and 18) were found to be the most potent antioxidants. 
Conjugates with alkyl, imino and thio group showed least antioxidant 
activity. 
Conclusion
A novel series of Schiff base analogues of amino acids-imidazole 
conjugates has been presented in this work. These compounds 
were evaluated for antibacterial and antifungal activities by agar 
well diffusion method. Activity profile revealed that compounds 
containing aromatic amino acids have shown profound results along 
with the beneficiary electron loving hydroxyl groups. Presence of thio 
(Met) and imino (Pro) amino acids have shown moderate activity 
compared to Lys, a basic amino acid. These target molecules have 
exhibited selective activity against A. niger fungal species and hence 
these could be used to treat fungal infections. In case of antioxidant 
activity compounds containing phenyl ring, indole ring and –OH 
(phenolic) group showed remarkable activity which may be due to 
electron donating activity and resonating property of phenyl ring. 
Compounds like 22, 23, 24, 25, 26, and 27 showed least activity which 
could be be due to long alkyl group and also may be due to thio group 
in methionine.
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Scheme: Schematic for target compounds
Comp. No. Xaa R1 R2 R3
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23 OH OH OH




26 OH OH OH
27 OCH3 OCH3 OCH3
Reagents and Conditions: (i) 4-Chloro benzyl chloride, K2CO3, acetone, reflux, 
12 h (ii) 0.1 N NaOH, MeOH, 50-55 °C, 5 h (iii) EDCI, HOBt, NMM, 0-5 °C, 15 
h (iv) Hydrazine hydrate, EtOH, reflux, 10 h (v) Substituted aldehydes, EtOH, 
AcOH, reflux, 14 h
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